Yoda Therapeutics Inc. (YODA), an AI-driven company that focuses on Central Nervous System (CNS) drugs, today announced the dosing of the first patient in the Phase 2 trial of YA-101 for Multiple ...

Researchers at Penn Vet and the University of Padova identified a novel variant connected to progressive retinal atrophy ...

The journey of recovery and success requires resilience, adaptability, and perseverance, as seen in astronauts and ...

The Department for Work and Pensions (DWP) has released new data which reveals that over 1.1 million adults across the UK are ...

Frederic L.W.V.J. Schaper, MD, PhD , director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at ...

Frederic L.W.V.J. Schaper, MD, PhD, director of Epilepsy Network Mapping at the Center for Brain Circuit Therapeutics at Brigham and Women’s Hospital and an instructor of neurology at Harvard Medical ...

In collaboration with a foundation that breeds service dogs for the visually impaired, researchers at the School of ...

MYOS CORP Secures 9th U.S. Patent, "Methods for Alleviating, Inhibiting or Reversing Muscle Disuse Atrophy in Mammals." "This is a major milestone for MYOS," said Joseph Mannello, CEO of MYOS CORP.

It's estimated that about a third of the population live with some form of muscle or joint problem and those most severely ...

NASA astronauts Barry Wilmore and Sunita Williams return after 9 months in space, revealing shocking physical transformations ...

After a grueling nine-month mission aboard the International Space Station, astronaut Sunita Williams returned to Earth ...

Novartis' OAV101 IT gene therapy showed positive results in Phase 3 trials for SMA, with data supporting its potential as a ...